Biomarker linked to male hair loss found to determine COVID-19 severity
May 7, 2021Medical Communications COVID-19, hair loss
Findings presented at the European Academy of Dermatology and Venereology (EADV) Spring Symposium suggest that men with genetic characteristics (phenotypes) …
GSK lupus treatment approved by European Commission
May 6, 2021GSK, Lupus, lupus treatment, pharma, pharma news
GSK’s Benlysta treatment, for patients with active lupus nephritis (LN) in addition to systemic lupus erythematosus (SLE), has been approved …
AstraZeneca to collaborate with Alchemab on prostate cancer research
May 6, 2021AstraZeneca, prostate cancer
AstraZeneca have announced a new collaboration with Cambridge-based biotech company Alchemab, with the aim of accelerating prostate cancer research. Alchemab …
Canada first country to authorise Pfizer vaccine in children aged 12-15
May 6, 2021COVID-19, Canada, Pfizer, Vaccine
Canada has become the first country to authorise the use of Pfizer’s COVID-19 vaccine for children aged between 12 and …
COVID-19: Moderna booster shots appear to increase immunity
May 6, 2021COVID-19, COVID-19 vaccine, Moderna, covid news, pharma, pharma news
Moderna’s mRNA booster jabs for people already vaccinated against COVID-19 have shown positive initial data in a Phase II study …
Sanofi to collaborate with Stanford University in immunology research
May 6, 2021Sanofi
Sanofi has entered into a three-year research collaboration with Stanford University School of Medicine, working to advance the understanding of …
Pharmafile.com’s weekly COVID-19 news round-up
May 5, 2021Research and Development COVID-19, COVID-19 vaccine, covid 19 news, covid-19 news, pharma, pharma news
The past week has seen more COVID-19 vaccine and treatment news: Moderna will supply up to 500 million jabs to …
Theramex releases Vitamin D gel aimed at women
May 5, 2021Research and Development Theramex, osteoporosis, pharma, pharma news, vitamin d
Theramex has launched a new gel for Vitamin D deficiency, in the hope that it will particularly treat women experiencing …
UK government to invest £29.3 million on COVID-19 variant testing
May 5, 2021Research and Development COVID-19, UK government, Vaccine, variants
The UK government has announced an investment of £29.3 million, on top of the £19.7 million already pledged, to be …
Janssen submits MAA to EMA for novel CAR-T cell therapy
May 5, 2021Research and Development EMA, EU, Janssen, multiple myeloma
Janssen have submitted a Marketing Authorisation Application (MAA) to the EMA seeking approval of cilta-cel, an investigational B cell maturation …
New HIV prevention drug application submitted to FDA
May 5, 2021Research and Development FDA, HIV
ViiV Healthcare have initiated a rolling submission of a new drug application (NDA) with the FDA for their long-acting HIV …
AstraZeneca drug approved by FDA for kidney disease treatment
May 4, 2021Manufacturing and Production AstraZeneca, FDA, kidney disease, pharma, pharma news
AstraZeneca’s Farxiga drug has been approved for the treatment of chronic kidney disease (CKD) in the US by the FDA.
NICE finds more SMA patients eligible for £75,000 a vial drug
May 4, 2021Manufacturing and Production, Sales and Marketing NICE, sma
NICE has announced that more people with the rare genetic disorder spinal muscular atrophy (SMA) are to benefit from nusinersen, …
Novartis eye treatment for diabetics shows positive results in Phase III trial
May 4, 2021Manufacturing and Production DME, Novartis, diabetic macular edema, macular edema, pharma, pharma news
Novartis’ Beovu treatment for diabetic macular edema (DME) – an eye condition that can cause blindness – has shown positive …
Needle-free pandemic influenza vaccine sees preclinical proof-of-concept
May 4, 2021Manufacturing and Production, Sales and Marketing Vaccine technology
Enesi Pharma, a US biotechnology company developing novel vaccination products, announced the development of a solid-dose recombinant H7N9 pandemic influenza …
Moderna to supply up to 500 million COVID-19 vaccines to COVAX
May 4, 2021Manufacturing and Production, Sales and Marketing COVAX, COVID-19, Moderna, Vaccine, WHO
Moderna have announced a supply agreement with Gavi, the Vaccine Alliance, for up to 500 million doses of their COVID-19 …
Pharmafile.com’s top 10 news stories of the week
April 30, 2021Medical Communications COVID-19, covid 19 news, covid-19 news, news roundup, pharma, pharma news
Among our top 10 stories this week: In COVID news, an app has revealed the most common side effects for …
Celltrion’s COVID-19 treatment shows promise against South African variant
April 30, 2021Medical Communications COVID-19, celltrion, covid 19 news, covid-19 news, covid-19 treatment, pharma, pharma news
Celltrion’s regdanvimab treatment for COVID-19 has shown itself to be effective against the South African variant of the virus, according …
Melanoma market to reach $7.4bn by 2029
April 30, 2021Medical Communications melanoma
A report from GlobalData, Melanoma – Global Drug Forecast and Market Analysis to 2029, has predicted the melanoma industry will …
Scipher Medicine to expand into autoimmune disease therapeutics
April 30, 2021Medical Communications AI, autoimmune diseases
Scipher Medicine, a precision immunology company, announced the launch on Scipher Therapeutics on Thursday, marking the company’s shift towards the …
Latest content
